Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are male and aged 18 or older
- People who have prostate cancer that has spread to other parts of the body and is no longer responding to hormone-lowering treatment
- People who have started taking a medication called olaparib within at least the last two months before entering the study, either at their doctor's decision or through a funded early access program
- People who have been told about the data collection involved in this study and do not object to it
- For those who started olaparib through the early access program and are still alive: people who have been informed verbally and/or in writing about this study and do not object to their data being stored electronically or checked for quality (as confirmed by their doctor)
- For those who started olaparib through the early access program and have since passed away: people who did not object to their data being used for research purposes during their lifetime
Who may not be able to join:
- People who object to having their personal data collected as part of this study
- People who were taking part in another clinical trial testing an experimental prostate cancer drug within the 30 days before starting olaparib
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-877-240-9479
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to treatment discontinuation (TTD)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.